<p>Susquehanna Fundamental Investments LLC 在第四季度購買了 Waters Co.（紐約證券交易所代碼：WAT - 免費報告）的新股份，具體信息在其最近向證券交易委員會的披露中顯示。該基金購買了 2,300 股該醫療儀器供應商的股票，價值約 853,000 美元。</p>
<ul>
<li>安捷倫科技因 “永恆化學品” 打擊而蓬勃發展</li>
</ul>
<p>其他幾家機構投資者和對沖基金也對該公司的持倉進行了調整。先鋒集團在第四季度將其在 Waters 的持股比例提高了 0.3%。先鋒集團目前擁有 7,098,668 股該醫療儀器供應商的股票，價值 2,633,464,000 美元，此前在上個季度又購買了 19,456 股。Wealthfront Advisers LLC 在第四季度將其在 Waters 的持倉提高了 106,144.4%。Wealthfront Advisers LLC 目前擁有 3,087,461 股該醫療儀器供應商的股票，價值 1,145,386,000 美元，此前在上個季度又購買了 3,084,555 股。Alliancebernstein L.P. 在第四季度將其在 Waters 的持股提高了 8.7%。Alliancebernstein L.P. 目前擁有 2,654,002 股該醫療儀器供應商的股票，價值 984,582,000 美元，此前在上個季度又購買了 212,364 股。Geode Capital Management LLC 在第四季度將其在 Waters 的持倉提高了 2.5%。Geode Capital Management LLC 目前擁有 1,451,445 股該醫療儀器供應商的股票，價值 537,053,000 美元，此前在上個季度又購買了 34,762 股。最後，AKO Capital LLP 在第四季度將其在 Waters 的持股提高了 3.2%。AKO Capital LLP 目前擁有 815,379 股該醫療儀器供應商的股票，價值 302,489,000 美元，此前在上個季度又購買了 25,172 股。94.01% 的股票由機構投資者和對沖基金持有。</p>
<h2>分析師設定新目標價</h2>
<p>幾家券商已對 WAT 發佈了報告。瑞銀集團將 Waters 的目標價從 405.00 美元上調至 410.00 美元，並在 2 月 13 日的報告中給予該股票 “中性” 評級。桑福德·C·伯恩斯坦在 4 月 16 日的研究報告中設定了 400.00 美元的目標價，並給予該股票 “跑贏大盤” 評級。富國銀行將 Waters 的目標價從 415.00 美元上調至 420.00 美元，並在 2 月 13 日的報告中給予該公司 “增持” 評級。StockNews.com 在 2 月 25 日的研究報告中將 Waters 的評級從 “買入” 下調至 “持有”。最後，貝爾德 R W 在 3 月 26 日的研究報告中將 Waters 的評級從 “持有” 上調至 “強力買入”。十位股票研究分析師對該股票給予了 “持有” 評級，七位給予了 “買入” 評級，兩位給予了 “強力買入” 評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “適度買入”，共識目標價為 392.13 美元。</p>
<ul>
<li>醫療股票 Waters、安捷倫、Illumina 顯示增長潛力</li>
</ul>
<p><strong>查看我們關於 WAT 的最新報告</strong></p>
<h2>Waters 股票表現</h2>
<p>紐約證券交易所：WAT 週五開盤價為 351.16 美元。該公司的速動比率為 0.65，流動比率為 0.94，債務與股本比率為 1.14。Waters Co. 的 52 周低點為 279.24 美元，52 周高點為 423.56 美元。該公司的 50 日簡單移動平均線為 352.54 美元，200 日簡單移動平均線為 369.92 美元。該股票的市值為 208.9 億美元，市盈率為 32.79，市盈增長比率為 3.79，貝塔值為 1.04。</p>
<p>Waters（紐約證券交易所：WAT - 獲取免費報告）最近在 2 月 12 日星期三發佈了季度財報。該醫療儀器供應商報告每股收益（EPS）為 4.10 美元，超出分析師共識預期的 4.02 美元，超出幅度為 0.08 美元。Waters 的淨利潤率為 21.56%，股本回報率為 46.31%。分析師預計 Waters Co. 在當前財年將發佈 12.86 美元的每股收益。</p>
<h2>Waters 公司簡介</h2>
<p>（免費報告）</p>
<p>Waters Corporation 在亞洲、美洲和歐洲提供分析工作流程解決方案。它通過兩個部門運營：Waters 和 TA。該公司設計、製造、銷售和服務高效和超高效液相色譜以及質譜（MS）技術系統和支持產品，包括色譜柱、其他消耗品和保修後服務計劃。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票比 Waters 更好</li>
<li>3 只股票保護您的投資組合免受冠狀病毒傳播影響</li>
<li>Meta 在第一季度財報中表現出色 - 注意第二季度的關税影響</li>
<li>什麼是納斯達克證券交易所？</li>
<li>亞馬遜財報：2 個值得關注的理由，1 個需要謹慎的理由</li>
<li>5 美元以下的最佳股票</li>
<li>Palantir 財報：1 個看漲信號和 1 個關注領域</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Waters 嗎？</h2>
<p>在考慮投資 Waters 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Waters 並不在其中。</p>
<p>雖然 Waters 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

沃特世

<p>Susquehanna Fundamental Investments LLC 已經在沃特世 (NYSE:WAT) 中獲得了新的股份，購買了價值約 853,000 美元的 2,300 股。其他機構投資者，包括先鋒集團和 Wealthfront Advisers，也增加了他們在沃特世的持倉。分析師為該股票設定了新的價格目標，普遍評級為 “適度買入”，目標價格為 392.13 美元。沃特世報告每股收益為 4.10 美元，超出預期，市值為 208.9 億美元</p>

<p>Susquehanna Fundamental Investments LLC purchased a new position in shares of Waters Co. (NYSE:WAT - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,300 shares of the medical instruments supplier's stock, valued at approximately $853,000.</p>
<div class="lb-trans"><p>Susquehanna Fundamental Investments LLC 在第四季度購買了 Waters Co.（紐約證券交易所代碼：WAT - 免費報告）的新股份，具體信息在其最近向證券交易委員會的披露中顯示。該基金購買了 2,300 股該醫療儀器供應商的股票，價值約 853,000 美元。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷倫科技因 “永恆化學品” 打擊而蓬勃發展</li>
</ul>
</div><p>Several other institutional investors and hedge funds have also made changes to their positions in the business. Vanguard Group Inc. lifted its stake in Waters by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 7,098,668 shares of the medical instruments supplier's stock worth $2,633,464,000 after purchasing an additional 19,456 shares during the last quarter. Wealthfront Advisers LLC lifted its position in shares of Waters by 106,144.4% during the 4th quarter. Wealthfront Advisers LLC now owns 3,087,461 shares of the medical instruments supplier's stock worth $1,145,386,000 after buying an additional 3,084,555 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in shares of Waters by 8.7% in the 4th quarter. Alliancebernstein L.P. now owns 2,654,002 shares of the medical instruments supplier's stock valued at $984,582,000 after buying an additional 212,364 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Waters by 2.5% in the 4th quarter. Geode Capital Management LLC now owns 1,451,445 shares of the medical instruments supplier's stock valued at $537,053,000 after buying an additional 34,762 shares during the last quarter. Finally, AKO Capital LLP raised its stake in Waters by 3.2% during the 4th quarter. AKO Capital LLP now owns 815,379 shares of the medical instruments supplier's stock worth $302,489,000 after acquiring an additional 25,172 shares in the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他幾家機構投資者和對沖基金也對該公司的持倉進行了調整。先鋒集團在第四季度將其在 Waters 的持股比例提高了 0.3%。先鋒集團目前擁有 7,098,668 股該醫療儀器供應商的股票，價值 2,633,464,000 美元，此前在上個季度又購買了 19,456 股。Wealthfront Advisers LLC 在第四季度將其在 Waters 的持倉提高了 106,144.4%。Wealthfront Advisers LLC 目前擁有 3,087,461 股該醫療儀器供應商的股票，價值 1,145,386,000 美元，此前在上個季度又購買了 3,084,555 股。Alliancebernstein L.P. 在第四季度將其在 Waters 的持股提高了 8.7%。Alliancebernstein L.P. 目前擁有 2,654,002 股該醫療儀器供應商的股票，價值 984,582,000 美元，此前在上個季度又購買了 212,364 股。Geode Capital Management LLC 在第四季度將其在 Waters 的持倉提高了 2.5%。Geode Capital Management LLC 目前擁有 1,451,445 股該醫療儀器供應商的股票，價值 537,053,000 美元，此前在上個季度又購買了 34,762 股。最後，AKO Capital LLP 在第四季度將其在 Waters 的持股提高了 3.2%。AKO Capital LLP 目前擁有 815,379 股該醫療儀器供應商的股票，價值 302,489,000 美元，此前在上個季度又購買了 25,172 股。94.01% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>Several brokerages have issued reports on WAT. UBS Group raised their price objective on Waters from $405.00 to $410.00 and gave the stock a &#34;neutral&#34; rating in a report on Thursday, February 13th. Sanford C. Bernstein set a $400.00 price target on Waters and gave the stock an &#34;outperform&#34; rating in a research report on Wednesday, April 16th. Wells Fargo &amp; Company increased their price objective on Waters from $415.00 to $420.00 and gave the company an &#34;overweight&#34; rating in a report on Thursday, February 13th. StockNews.com lowered shares of Waters from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, February 25th. Finally, Baird R W upgraded shares of Waters from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Wednesday, March 26th. Ten equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $392.13.</p>
<div class="lb-trans"><p>幾家券商已對 WAT 發佈了報告。瑞銀集團將 Waters 的目標價從 405.00 美元上調至 410.00 美元，並在 2 月 13 日的報告中給予該股票 “中性” 評級。桑福德·C·伯恩斯坦在 4 月 16 日的研究報告中設定了 400.00 美元的目標價，並給予該股票 “跑贏大盤” 評級。富國銀行將 Waters 的目標價從 415.00 美元上調至 420.00 美元，並在 2 月 13 日的報告中給予該公司 “增持” 評級。StockNews.com 在 2 月 25 日的研究報告中將 Waters 的評級從 “買入” 下調至 “持有”。最後，貝爾德 R W 在 3 月 26 日的研究報告中將 Waters 的評級從 “持有” 上調至 “強力買入”。十位股票研究分析師對該股票給予了 “持有” 評級，七位給予了 “買入” 評級，兩位給予了 “強力買入” 評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “適度買入”，共識目標價為 392.13 美元。</p>
</div><ul>
<li>Medical Stocks Waters, Agilent, Illumina Show Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>醫療股票 Waters、安捷倫、Illumina 顯示增長潛力</li>
</ul>
</div><p><strong>Check Out Our Latest Report on WAT</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 WAT 的最新報告</strong></p>
</div><h2>Waters Stock Performance</h2>
<div class="lb-trans"><h2>Waters 股票表現</h2>
</div><p>NYSE:WAT opened at $351.16 on Friday. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $423.56. The firm's fifty day simple moving average is $352.54 and its 200-day simple moving average is $369.92. The stock has a market cap of $20.89 billion, a PE ratio of 32.79, a price-to-earnings-growth ratio of 3.79 and a beta of 1.04.</p>
<div class="lb-trans"><p>紐約證券交易所：WAT 週五開盤價為 351.16 美元。該公司的速動比率為 0.65，流動比率為 0.94，債務與股本比率為 1.14。Waters Co. 的 52 周低點為 279.24 美元，52 周高點為 423.56 美元。該公司的 50 日簡單移動平均線為 352.54 美元，200 日簡單移動平均線為 369.92 美元。該股票的市值為 208.9 億美元，市盈率為 32.79，市盈增長比率為 3.79，貝塔值為 1.04。</p>
</div><p>Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. Analysts expect that Waters Co. will post 12.86 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Waters（紐約證券交易所：WAT - 獲取免費報告）最近在 2 月 12 日星期三發佈了季度財報。該醫療儀器供應商報告每股收益（EPS）為 4.10 美元，超出分析師共識預期的 4.02 美元，超出幅度為 0.08 美元。Waters 的淨利潤率為 21.56%，股本回報率為 46.31%。分析師預計 Waters Co. 在當前財年將發佈 12.86 美元的每股收益。</p>
</div><h2>Waters Company Profile</h2>
<div class="lb-trans"><h2>Waters 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.</p>
<div class="lb-trans"><p>Waters Corporation 在亞洲、美洲和歐洲提供分析工作流程解決方案。它通過兩個部門運營：Waters 和 TA。該公司設計、製造、銷售和服務高效和超高效液相色譜以及質譜（MS）技術系統和支持產品，包括色譜柱、其他消耗品和保修後服務計劃。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Waters</li>
<li>3 Stocks to Protect Your Portfolio from the Coronavirus Contagion</li>
<li>Meta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2</li>
<li>What is the NASDAQ Stock Exchange?</li>
<li>Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious</li>
<li>Best Stocks Under $5.00</li>
<li>Palantir Earnings: 1 Bullish Signal and 1 Area of Concern</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Waters 更好</li>
<li>3 只股票保護您的投資組合免受冠狀病毒傳播影響</li>
<li>Meta 在第一季度財報中表現出色 - 注意第二季度的關税影響</li>
<li>什麼是納斯達克證券交易所？</li>
<li>亞馬遜財報：2 個值得關注的理由，1 個需要謹慎的理由</li>
<li>5 美元以下的最佳股票</li>
<li>Palantir 財報：1 個看漲信號和 1 個關注領域</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=WAT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Waters Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Waters 嗎？</h2>
</div><p>Before you consider Waters, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮投資 Waters 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Waters 並不在其中。</p>
</div><p>While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Waters 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Susquehanna Fundamental Investments LLC 購入了沃特世公司（NYSE:WAT）的新股權